Vialwirebiotech, curated
November 21, 2026, 9:28 AM
October 6, 2026
- 9:59 AM · STAT News9:59 AMSTAT+: FDA spells out 2027 AI guidance plans — STAT News
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMEDG-4131 restores muscle performance in NEM6 mice — BioWorld
- 9:00 AM · BioWorld9:00 AMMerck KGaA describes new YAP1/TEAD interaction inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMNovel PKR1 agonist shows dual metabolic and muscle-preserving activity — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA approves IND for Crescent Biopharma’s CR-002 — BioWorld
- 9:00 AM · BioWorld9:00 AMBeactica selects BEA-28 as preclinical TEAD degrader candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMFinancing at Sereneuro Therapeutics to advance pain pipeline — BioWorld
- 9:00 AM · BioWorld9:00 AMChinese researchers discover new STAT6 degradation inducers — BioWorld
- 9:00 AM · BioWorld9:00 AMZag Bio’s ZAG-101 enters clinic for type 1 diabetes — BioWorld
- 9:00 AM · BioWorld9:00 AMHinova Pharmaceuticals details new GLP-1R agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMRewind advances GPR17 antagonist program for remyelination — BioWorld
- 9:00 AM · BioWorld9:00 AMEquillium’s AhR modulator EQ-504 cleared for clinic in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMIambic files IND for brain-penetrant KIF18A inhibitor IAM-217 — BioWorld
- 9:00 AM · BioWorld9:00 AMMedicovestor’s MC-001 gains IND clearance for pancreatic cancer — BioWorld
- 8:00 AM · BioWorld8:00 AMClinics: Psoriasis data from Ascletis, Takeda — BioWorld
- 8:00 AM · BioWorld8:00 AMDeals/M&As: Amberstone-Henlius, Sun-LIB and more — BioWorld
- 8:00 AM · BioWorld8:00 AMA&As: Liu new head of Adlai Nortye IR and PR — BioWorld
- 6:00 AM · Drug Discovery World6:00 AMGRK2 modulator reduces fat mass while building muscle — Drug Discovery World
- 5:28 AM · Pharmaceutical Technology5:28 AMPacira partners with Molteni for Exparel commercialisation — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMNuclera appoints Carl Raimond as Chief Executive Officer — Drug Discovery World
- 4:00 AM · Drug Discovery World4:00 AMMSD buys oral KRAS G12D (ON) inhibitor for $2.13 billion — Drug Discovery World
- 4:00 AM · Labiotech (EU)
October 5, 2026
- 3:30 PM · FT — Pharmaceuticals3:30 PMWhen a label costs you $4bn in market cap — FT — Pharmaceuticals
- 12:00 PM · BioWorld12:00 PMAlector’s GCase ERT ‘Spurs’ $1.27B Genentech deal — BioWorld
- 12:00 PM · BioWorld12:00 PMGE to acquire Sofie Biosciences for $945M in cash — BioWorld
- 12:00 PM · BioWorld12:00 PMIbogaine therapies on the horizon? — BioWorld
- 9:55 AM · STAT News9:55 AMSTAT+: Lilly’s Jaypirca approved as first-line CLL therapy — STAT News
- 9:00 AM · BioWorld9:00 AMXtalpi initiates IND-enabling studies for hair loss program — BioWorld
- 9:00 AM · BioWorld9:00 AMFinancing at Celaid Therapeutics to advance CLD-001 — BioWorld
- 9:00 AM · BioWorld9:00 AMHanchorbio’s second trispecific immunotherapy to enter clinic — BioWorld
- 9:00 AM · BioWorld9:00 AMTaili Biopharmaceutical discovers new antibody-drug conjugates — BioWorld
- 9:00 AM · BioWorld9:00 AMIbio’s IBIO-610 reshapes weight loss composition — BioWorld
- 9:00 AM · BioWorld9:00 AMNCI grant supports Saros Therapeutics’ nanoparticle immunotherapy — BioWorld
- 9:00 AM · BioWorld9:00 AMInventisbio identifies new STAT6-targeting PROTACs — BioWorld
- 9:00 AM · BioWorld9:00 AMPfizer describes new APLNR agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMNew 17β-neriifolin derivatives reported in Enkang Pharmaceuticals patent — BioWorld
- 9:00 AM · BioWorld
- 8:19 AM · STAT News
- 3:56 AM · Pharmaceutical Technology3:56 AMBayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US — Pharmaceutical Technology